Mira Pharmaceuticals Inc (NASDAQ: MIRA) is -19.21% lower on its value in year-to-date trading and has touched a low of $0.51 and a high of $5.01 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MIRA stock was last observed hovering at around $0.86 in the last trading session, with the day’s gains setting it 0.06%.
Currently trading at $0.92, the stock is -0.73% and -10.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.78 million and changing 7.08% at the moment leaves the stock -30.70% off its SMA200. MIRA registered 10.75% gain for a year compared to 6-month gain of -16.27%. The firm has a 50-day simple moving average (SMA 50) of $1.03326 and a 200-day simple moving average (SMA200) of $1.327405.
The stock witnessed a -25.12% loss in the last 1 month and extending the period to 3 months gives it a -22.61%, and is 2.65% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.16% over the week and 10.30% over the month.
Mira Pharmaceuticals Inc (MIRA) has around 5 employees, a market worth around $15.48M and $0.00M in sales. Distance from 52-week low is 80.59% and -81.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-356.98%).
The EPS is expected to grow by 14.29% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
21.0 institutions hold shares in Mira Pharmaceuticals Inc (MIRA), with institutional investors hold 8.70% of the company’s shares. The shares outstanding are 16.56M, and float is at 12.48M with Short Float at 4.61%. Institutions hold 6.98% of the Float.
Mira Pharmaceuticals Inc (MIRA) Insider Activity
The most recent transaction is an insider sale by Aminov Erez, the company’s Chief Executive Officer. SEC filings show that Aminov Erez sold 55,410 shares of the company’s common stock on Nov 19 ’24 at a price of $1.39 per share for a total of $77020.0. Following the sale, the insider now owns 1.11 million shares.
Mira Pharmaceuticals Inc disclosed in a document filed with the SEC on Nov 20 ’24 that Aminov Erez (Chief Executive Officer) sold a total of 44,590 shares of the company’s common stock. The trade occurred on Nov 20 ’24 and was made at $1.27 per share for $56629.0. Following the transaction, the insider now directly holds 1.06 million shares of the MIRA stock.
Still, SEC filings show that on Nov 19 ’24, Erez Aminov (Affiliate) Proposed Sale 100,000 shares at an average price of $1.41 for $0.14 million. The insider now directly holds shares of Mira Pharmaceuticals Inc (MIRA).
